DHCNI Q1 2026 Earnings EPS Misses Expectations Amid Challenging Real Estate Market VICR Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Significant EPS Miss Amid PreClinical Stage Operations Renasant Q1 2026 Earnings EPS Surpasses Estimates as Shares Edge Lower GH Q1 2026 Earnings EPS Beats Estimates Amidst Focus on Precision Oncology TWAV Q3 2022 Earnings Steep EPS Miss Raises Concerns Over Profitability